Works matching IS 10538569 AND DT 2024 AND VI 33 AND IP 5

Results: 17

Emulation of randomized trials of direct oral anticoagulants with claims data and implications for new Factor XI inhibitors.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5813
By:
- Wang, Shirley V.;
- Lin, Kueiyu Joshua;
- Schneeweiss, Sebastian
Publication type:
Article
The impact of hospitalization on inappropriate prescribing and polypharmacy in older patients: A descriptive cross‐sectional study.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5812
By:
- Weiss, Ori;
- Eyre, Andy;
- Ellenbogen, Danny Alon;
- Stein, Gideon Y.
Publication type:
Article
Do efficacy results obtained from randomized controlled trials translate to effectiveness data from observational studies for relapsing–remitting multiple sclerosis?
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5810
By:
- Verweij, Stefan;
- Ahmed, Wouter;
- Zhou, Guiling;
- Mavridis, Dimitris;
- Nikolakopoulos, Stavros;
- Elferink, Andre J.;
- Rengerink, Katrien Oude;
- Bijlsma, Maarten J.;
- Mol, Peter G. M.;
- Hak, Eelko
Publication type:
Article
Application of multiple validated algorithms for identifying incident breast cancer among individuals with atopic dermatitis.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5808
By:
- Campos, Adriana;
- Ramasubramanian, Ramya;
- Wong, Cherise;
- Marcus, Andrea Fleisch
Publication type:
Article
Issue Information.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5807
Publication type:
Article
Matching study design to prescribing intention: The prevalent new‐user design for studying abuse‐deterrent formulations of opioids.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5805
By:
- DiPrete, Bethany L.;
- Oh, GYeon;
- Moga, Daniela C.;
- Dasgupta, Nabarun;
- Slavova, Svetla;
- Slade, Emily;
- Delcher, Chris;
- Pence, Brian W.;
- Ranapurwala, Shabbar I.
Publication type:
Article
Non‐adherence and non‐persistence with antiretroviral treatment in Belgium: A real‐world evaluation using a pharmacy database, 2018–2021.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5804
By:
- Ilboudo, Dieudonné;
- Mbouche, Patricia;
- Sommet, Agnès;
- Van Wilder, Philippe;
- Kirakoya‐Samadoulougou, Fati
Publication type:
Article
Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5803
By:
- Saito, Kyoko;
- Gabbeta, Avinash;
- Mulvihill, Evan;
- Al‐Jaberi, Lina;
- Beukelman, Timothy;
- Lewis, James D.;
- Rose, Carlos D.;
- Strom, Brian L.;
- Horton, Daniel B.
Publication type:
Article
Sex disparities in medication changes after metformin initiation are associated with small, clinically non‐relevant, sex differences in HbA1c levels during follow‐up.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5802
By:
- de Vries, Sieta T.;
- de Vos, Stijn;
- Oktora, Monika P.;
- Denig, Petra
Publication type:
Article
Risk of acute pancreatitis among new users of empagliflozin compared to sulfonylureas in patients with type 2 diabetes: A post‐authorization safety study.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5800
By:
- Fazeli Farsani, Soulmaz;
- Iglay, Kristy;
- Zhang, Ling;
- Niyonkuru, Christian;
- Nessralla, Laurieann;
- Girman, Cynthia J.
Publication type:
Article
Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study program.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5799
By:
- de Vogel, Stefan;
- Seeger, John D.;
- Arana, Alejandro;
- Margulis, Andrea V.;
- McQuay, Lisa J.;
- Perez‐Gutthann, Susana;
- Hallas, Jesper;
- Kristiansen, Nina Sahlertz;
- Linder, Marie;
- Odsbu, Ingvild;
- Suehs, Brandon;
- Xu, Yihua;
- Uribe, Claudia;
- Appenteng, Kwame;
- Robinson, Noah Jamie
Publication type:
Article
Comparing survival in trial‐ versus routine‐care advanced urothelial cancer patients on immune checkpoint blockade.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5798
By:
- Wang, Lucy S.;
- Hubbard, Rebecca A.;
- Mamtani, Ronac
Publication type:
Article
Rising cases of drug‐induced pulmonary fibrosis: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database, 2000–2022.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5797
By:
- McCall, Kenneth L.;
- Hennig, Kelsey R.;
- Abe, Zachary T.;
- Dattler, Danielle N.;
- Hurd, Karyssa L.;
- Portnoy, Sophie L.;
- Zagoria, Zoey J.
Publication type:
Article
Use of quantitative bias analysis to evaluate single‐arm trials with real‐world data external controls.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5796
By:
- Gray, Christen;
- Ralphs, Eleanor;
- Fox, Matthew P.;
- Lash, Timothy L.;
- Liu, Geoffrey;
- Kou, Tzuyung Doug;
- Rivera, Donna R.;
- Bosco, Jaclyn;
- Braun, Kim Van Naarden;
- Grimson, Fiona;
- Layton, Deborah
Publication type:
Article
Structured benefit–risk assessment for enoxaparin, in the context of its label extension, for the extended treatment of deep vein thrombosis and pulmonary embolism, and prevention of its recurrence in patients with active cancer.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5795
By:
- Kürzinger, Marie‐Laure;
- El‐Haddad, Chantal;
- Gouin‐Soboleva, Tatiana;
- Fazekas, Zita;
- Granados, Denis;
- Benito‐Garcia, Elizabeth;
- Djoudi, Yasmina
Publication type:
Article
Risk of bleeding amongst warfarin and direct oral anticoagulant users prescribed immediate antibiotics for respiratory tract infection: Cohort study.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5794
By:
- Ahmed, Haroon;
- Reeve, Nicola;
- Farewell, Daniel;
- Hamilton, Fergus;
- Ponsford, Mark;
- Hippisley‐Cox, Julia;
- Noble, Simon
Publication type:
Article
Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review.
Published in:
Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5787
By:
- Gini, Rosa;
- Pajouheshnia, Romin;
- Gardarsdottir, Helga;
- Bennett, Dimitri;
- Li, Lin;
- Gulea, Claudia;
- Wientzek‐Fleischmann, Angelika;
- Bazelier, Marloes T.;
- Burcu, Mehmet;
- Dodd, Caitlin;
- Durán, Carlos E.;
- Kaplan, Sigal;
- Lanes, Stephan;
- Marinier, Karine;
- Roberto, Giuseppe;
- Soman, Kanaka;
- Zhou, Xiaofeng;
- Platt, Robert;
- Setoguchi, Soko;
- Hall, Gillian C.
Publication type:
Article